RecruitingNot applicableNCT07473635
2
studies recruiting now
as of 7 Sept 2026
14
studies registered in total
as of 7 Sept 2026
2
countries with a recruiting site
as of 7 Sept 2026
16 Mar 2026
most recent study posted
among recruiting studies
Recruiting trials
Showing the 2 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
Search all Complex regional pain syndrome type 2 studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Complex regional pain syndrome type 2 study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Complex regional pain syndrome type 2
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.
Treatments being studied
16 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Phase 3Human Immunoglobulin G (Flebogamma dif (previously flebogammadif))
Phase 3Ascorbic Acid (Ascor)
Phase 3Neridronic Acid
Phase 3Oxygen (Medicinal oxygen air liquide sante)
Phase 3Brezivaptan
Phase 3Zoledronic Acid Anhydrous
Phase 3Nitrous Oxide (Entonox)
Phase 2/3Lidocaine (Alphacaine)
+ 8 more in development
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).